Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction: Generalised anxiety disorder (GAD) is a significant mental health concern characterised by excessive and uncontrollable worry about everyday activities. Despite its prevalence, there is a scarcity of research on pharmacological management strategies for GAD, particularly within the Saudi Arabian context. This study aims to address this gap by identifying and evaluating the most commonly used pharmacological strategies among Saudi adults. It assesses the effectiveness of these strategies, examines factors influencing their choice and explores the prevalence and impact of adverse effects associated with them. Methods: This cross-sectional study employed stratified random sampling to select a representative sample of adults aged 18 years and older from various regions of Saudi Arabia. Participants provided data through self-administered questionnaires, which included information on sociodemographic characteristics, GAD symptoms, pharmacological strategies utilised, their effectiveness and any adverse effects. The study’s analytical approach encompassed statistical methods such as correlation, regression and Chi-square tests, aiming to uncover relationships and patterns among the collected data, particularly focusing on treatment efficacy and the occurrence of adverse effects. Results: The study findings revealed a demographic skew towards young adults (18–24 years), predominantly female, with a majority diagnosed with GAD and experiencing symptoms for < 6 months. A notable willingness to seek professional help was observed. The most commonly used pharmacological strategy was classified as ‘others’, with a high satisfaction rate among users. Adverse effects were infrequent, with a minority experiencing them frequently. Selective serotonin reuptake inhibitors demonstrated the highest mean improvement in GAD symptoms, indicating their effectiveness. The study also highlighted the significance of considering medication side effects, particularly for individuals more prone to adverse events. Conclusion: The research offers insightful contributions to understanding pharmacological strategies for managing GAD symptoms in the adult population of Saudi Arabia. The results underscore the importance of personalised treatment plans, taking into account the efficacy and side effect profiles of medications. These insights are crucial for healthcare professionals in formulating evidence-based treatment guidelines and improving patient outcomes. Furthermore, the findings highlight the areas for future research, particularly in optimising treatment strategies for GAD considering individual patient needs and responses to therapy.
Introduction: Generalised anxiety disorder (GAD) is a significant mental health concern characterised by excessive and uncontrollable worry about everyday activities. Despite its prevalence, there is a scarcity of research on pharmacological management strategies for GAD, particularly within the Saudi Arabian context. This study aims to address this gap by identifying and evaluating the most commonly used pharmacological strategies among Saudi adults. It assesses the effectiveness of these strategies, examines factors influencing their choice and explores the prevalence and impact of adverse effects associated with them. Methods: This cross-sectional study employed stratified random sampling to select a representative sample of adults aged 18 years and older from various regions of Saudi Arabia. Participants provided data through self-administered questionnaires, which included information on sociodemographic characteristics, GAD symptoms, pharmacological strategies utilised, their effectiveness and any adverse effects. The study’s analytical approach encompassed statistical methods such as correlation, regression and Chi-square tests, aiming to uncover relationships and patterns among the collected data, particularly focusing on treatment efficacy and the occurrence of adverse effects. Results: The study findings revealed a demographic skew towards young adults (18–24 years), predominantly female, with a majority diagnosed with GAD and experiencing symptoms for < 6 months. A notable willingness to seek professional help was observed. The most commonly used pharmacological strategy was classified as ‘others’, with a high satisfaction rate among users. Adverse effects were infrequent, with a minority experiencing them frequently. Selective serotonin reuptake inhibitors demonstrated the highest mean improvement in GAD symptoms, indicating their effectiveness. The study also highlighted the significance of considering medication side effects, particularly for individuals more prone to adverse events. Conclusion: The research offers insightful contributions to understanding pharmacological strategies for managing GAD symptoms in the adult population of Saudi Arabia. The results underscore the importance of personalised treatment plans, taking into account the efficacy and side effect profiles of medications. These insights are crucial for healthcare professionals in formulating evidence-based treatment guidelines and improving patient outcomes. Furthermore, the findings highlight the areas for future research, particularly in optimising treatment strategies for GAD considering individual patient needs and responses to therapy.
Introduction: Generalized anxiety disorder (GAD) is a significant mental health concern characterized by excessive and uncontrollable worry about everyday activities. Despite its prevalence, there is a scarcity of research on pharmacological management strategies for GAD, particularly within the Saudi Arabian context. This study aims to address this gap by identifying and evaluating the most commonly used pharmacological strategies among adults in Saudi Arabia. It will assess the effectiveness of these strategies, examine factors influencing the preference of these strategies, and explore the prevalence and impact of adverse effects associated with them. Methods: This cross-sectional study employed stratified random sampling to select a representative sample of adults aged 18 years and above from various regions of Saudi Arabia. Participants provided data through self-administered questionnaires, which included information on sociodemographic characteristics, GAD symptoms, pharmacological strategies utilized, their effectiveness, and any adverse effects. The study’s analytical approach encompassed statistical methods such as correlation, regression, and Chi-square tests, aiming to uncover relationships and patterns among the collected data, particularly focusing on treatment efficacy and the occurrence of adverse effects. Results: We found a demographic skewing among Saudi patients with GAD, particularly toward young adults aged 18–24 and women. The majority of these patients were diagnosed with GAD and had been experiencing symptoms for less than six months. In addition, there was a notable willingness among them to seek professional help. The most commonly used pharmacological strategy was classified as “Others,” with a high satisfaction rate reported by users. Adverse effects were infrequent, affecting only a minority of patients frequently. Selective serotonin reuptake inhibitors demonstrated the highest mean improvement in GAD symptoms, indicating their effectiveness. Our study also emphasized the importance of considering medication side effects, especially for individuals with a greater tendency to adverse events. Conclusion: This research emphasizes the importance of personalized treatment plans, medication efficacy, and side effect profiles for managing GAD in Saudi Arabia. It also underscores the need for evidence-based treatment guidelines and suggests areas for future research to optimize GAD treatment strategies based on individual patient needs and therapy responses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.